ipriflavone and tamoxifen

ipriflavone has been researched along with tamoxifen in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Reginster, JY	1
Aiello, FB; Caltagirone, S; Colasante, A; Maggiano, N; Musiani, P; Piantelli, M; Ranelletti, FO; Rinelli, A	1
Almadori, G; Cattani, P; Ferlini, C; Ferrandina, G; Lanza, P; Maggiano, N; Piantelli, M; Ranelletti, FO; Scambia, G	1

Reviews

1 review(s) available for ipriflavone and tamoxifen

Article	Year
Miscellaneous and experimental agents. The American journal of the medical sciences, 1997, Volume: 313, Issue:1 Topics: Anabolic Agents; Animals; Bone Density; Bone Remodeling; Bone Resorption; Estrogen Antagonists; Estrogens; Female; Hip Fractures; Humans; Insulin; Insulin-Like Growth Factor I; Isoflavones; Osteoporosis, Postmenopausal; Parathyroid Hormone; Strontium; Tamoxifen; Trace Elements	1997

Other Studies

2 other study(ies) available for ipriflavone and tamoxifen

Article	Year
Interaction with type II estrogen binding sites and antiproliferative activity of tamoxifen and quercetin in human non-small-cell lung cancer. American journal of respiratory cell and molecular biology, 1997, Volume: 17, Issue:1 Topics: Aged; Analgesics; Animals; Binding, Competitive; Carcinoma, Non-Small-Cell Lung; Cell Division; Cell Line; Cell Nucleus; Cytosol; DNA, Neoplasm; Estradiol; Female; Humans; Isoflavones; Kinetics; Lung Neoplasms; Male; Middle Aged; Quercetin; Rats; Receptors, Estrogen; Rutin; Tamoxifen; Tumor Cells, Cultured	1997
Growth-inhibitory effect of tamoxifen and quercetin and presence of type II estrogen binding sites in human laryngeal cancer cell lines and primary laryngeal tumors. International journal of cancer, 1998, Aug-31, Volume: 77, Issue:5 Topics: Apoptosis; Cell Cycle; Cell Division; Cell Line; Dose-Response Relationship, Drug; Estradiol; Humans; Isoflavones; Kinetics; Laryngeal Neoplasms; Quercetin; Receptors, Estrogen; Tamoxifen; Time Factors; Tumor Cells, Cultured; Tumor Stem Cell Assay	1998

Article

Year

Interaction with type II estrogen binding sites and antiproliferative activity of tamoxifen and quercetin in human non-small-cell lung cancer.

American journal of respiratory cell and molecular biology, 1997, Volume: 17, Issue:1

Topics: Aged; Analgesics; Animals; Binding, Competitive; Carcinoma, Non-Small-Cell Lung; Cell Division; Cell Line; Cell Nucleus; Cytosol; DNA, Neoplasm; Estradiol; Female; Humans; Isoflavones; Kinetics; Lung Neoplasms; Male; Middle Aged; Quercetin; Rats; Receptors, Estrogen; Rutin; Tamoxifen; Tumor Cells, Cultured

1997

Growth-inhibitory effect of tamoxifen and quercetin and presence of type II estrogen binding sites in human laryngeal cancer cell lines and primary laryngeal tumors.

International journal of cancer, 1998, Aug-31, Volume: 77, Issue:5

Topics: Apoptosis; Cell Cycle; Cell Division; Cell Line; Dose-Response Relationship, Drug; Estradiol; Humans; Isoflavones; Kinetics; Laryngeal Neoplasms; Quercetin; Receptors, Estrogen; Tamoxifen; Time Factors; Tumor Cells, Cultured; Tumor Stem Cell Assay

1998